Basic information Safety Supplier Related

H-PRO-LEU-GLY-NH2

Basic information Safety Supplier Related

H-PRO-LEU-GLY-NH2 Basic information

Product Name:
H-PRO-LEU-GLY-NH2
Synonyms:
  • MELANOCYTE STIMULATING HORMONE RELEASE INHIBITING FACTOR
  • MELANOCYTE STIMULATING HORMONE RELEASE INHIBITING FACTOR, AMIDE
  • MELANOCYTE STIMULATING HORMONE RELEASING FACTOR
  • MELANOSTATIN
  • H-PRO-LEU-GLY-NH2
  • L-Prolyl-L-leucylglycinamide, hemihydrate
  • L-prolyl-L-leucylglycinamide
  • MSH-RELEASE INHIBITING FACTOR
CAS:
2002-44-0
MF:
C13H24N4O3
MW:
284.35
EINECS:
217-902-7
Product Categories:
  • SignalTransduction
  • Melanocortin receptor
  • peptide
  • Elisa Kit-Mouse Elisa Kit
Mol File:
2002-44-0.mol
More
Less

H-PRO-LEU-GLY-NH2 Chemical Properties

Melting point:
122-123 °C(Solv: water (7732-18-5))
Boiling point:
626.2±55.0 °C(Predicted)
Density 
1.147±0.06 g/cm3(Predicted)
storage temp. 
-15°C
solubility 
≥59.1 mg/mL in DMSO; ≥50 mg/mL in EtOH; ≥50 mg/mL in H2O
pka
14.10±0.20(Predicted)
form 
Lyophilized powder
Water Solubility 
Soluble in water.
Sequence
H-Pro-Leu-Gly-NH2
More
Less

H-PRO-LEU-GLY-NH2 Usage And Synthesis

Uses

L-Prolyl-L-leucylglycinamide is shown to be effective in treating human depression with greater efficacy and faster onset of action than traditional anti-depressants.Also, it is used in the synthesis of novel analogs to be tested for their ability to enhance the binding of [3H]-N-propylnorapomorphine to short isoform of human dopamine D2 receptors.

Definition

ChEBI: Melanostatin is an oligopeptide.

Biological Activity

melanocyte stimulating hormone release inhibiting factor,(c13h24n4o3), a tri-peptide with the sequence h2n-pro-leu-gly-amide, mw= 284.35. melanocyte-inhibiting factor (also known as pro-leu-gly-nh2, melanostatin, msh release-inhibiting hormone or mif-1) is an endogenous peptide fragment derived from cleavage of the hormone oxytocin, but having generally different actions in the body(1). mif-1 produces multiple effects, both blocking the effects of opioid receptor activation(2), while at the same time acting as a positive allosteric modulator of the d2 and d4 dopamine receptor subtypes, as well as inhibiting release of other neuropeptides such as alpha-msh, and potentiating melatonin activity(3). mif-1 is unusually resistant to metabolism in the bloodstream, and crosses the blood–brain barrier easily, though it is poorly active orally and is usually injected.figure1 formula of melanocyte stimulating hormone release inhibiting factor

storage

-20°C (desiccate)

References

1. Celis ME, Taleisnik S, Walter R (July 1971). "Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone". Proceedings of the National Academy of Sciences of the United States of America 68 (7): 1428–33.2. Contreras PC, Takemori AE (June 1984). "Effect of prolyl-leucyl-glycinamide and alpha-melanocyte-stimulating hormone on levorphanol-induced analgesia, tolerance and dependence". Life Sciences 34 (26): 2559–66.3. Sandyk R (May 1990). "MIF-induced augmentation of melatonin functions: possible relevance to mechanisms of action of MIF-1 inmovement disorders". The International Journal of Neuroscience 52 (1-2): 59–65.

H-PRO-LEU-GLY-NH2Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
GL Biochem (Shanghai) Ltd
Tel
21-61263452 13641803416
Email
ymbetter@glbiochem.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696
Email
info@hanhongsci.com
Chemsky (shanghai) International Co.,Ltd
Tel
021-50135380
Email
shchemsky@sina.com
ApexBio Technology LLC
Tel
+1-832-696-8203
Email
info@apexbt.com